US Patent 10695433 Pyrrolobenzodiazepine-antibody conjugates
Patent 10695433 was granted and assigned to Medimmune Limited on June, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 8 Mar, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
106954330
Date of Patent
June 30, 2020
0Patent Application Number
144348210
Date Filed
October 11, 2013
0Official Website
Patent Citations Received
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 31 Aug, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10695433 Pyrrolobenzodiazepine-antibody conjugates
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10695433
Date of patent
June 30, 2020
Patent application number
14434821
Date Filed
October 11, 2013
Patent primary examiner
Find more entities like US Patent 10695433 Pyrrolobenzodiazepine-antibody conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
